NTRK CONNECT - Experts Knowledge Share

Wednesday, January 20th 2021

16:00 -

17:30

CET

10:00 -

11:30

EST

00:00 -

01:30

JST (+1 Day)

About This Meeting

Current opinions on how to identify, test and treat NTRK fusion positive cancer. Learn about and discuss: -

Treating NTRK fusion cancer today and in the future
Testing methodologies and tumour-specific algorithms
Adverse events associated with TRK inhibitors

Meeting Materials

To view meeting materials, you need to be registered for the meeting.

Faculty

Prof. David Hong

University of Texas MD Anderson Cancer Center

Houston, USA

Prof. Frédérique Penault-Llorca

University of Clermont-Auvergne

France

Prof. Ezra Cohen

UC San Diego Health-Moores Cancer Center

California, USA

Faculty

Prof. David Hong

University of Texas MD Anderson Cancer Center

Houston, USA

Prof. Frédérique Penault-Llorca

University of Clermont-Auvergne

France

Prof. Ezra Cohen

UC San Diego Health-Moores Cancer Center

California, USA

This content is supported by an Independent Educational Grant from Bayer

COR2ED develops and implements high quality Independent Medical Education programmes to help improve the health of patients globally.

Bodenackerstrasse 17
4103 Bottmingen
Switzerland

Disclaimer: The material and content contained in the website engage.cor2ed.com is for healthcare professionals only. Although every effort is made to ensure that the material within this website is accurate and timely, it is provided for informational and educational purposes only. The information provided is not intended as a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country.
© Copyright 2021 | All Rights Reserved

Cookies Privacy Policy

NTRK CONNECT - Experts Knowledge Share

About This Meeting

Meeting Materials

Faculty

Prof. David Hong

Prof. Frédérique Penault-Llorca

Prof. Ezra Cohen

Faculty

Prof. David Hong

Prof. Frédérique Penault-Llorca

Prof. Ezra Cohen

Products

SUPPORT